Pfizer aimed to prepare the market with an unbranded, educational campaign for a gene therapy product targeting Duchenne muscular dystrophy—a rare condition. My team and I focused on creating content that would be engaging and informative for patients and caregivers. Over two years of meticulous work, we produced a variety of elements, including two animated videos using an orchestra analogy to explain the genetic condition, website modules, comprehensive campaign guidelines, patient brochures, and conference materials. To view the final results, please visit www.reimagineduchenne.com.